metoclopramide has been researched along with Neoplasm Metastasis in 4 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "19 mg/l with doses which varied considerably owing to marked scattering of pharmacokinetic parameters." | 6.66 | [Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach]. ( Brechot, JM; Delattre, C; Delfour, C; Dupeyron, JP; Guyon, F; Lebeau, B; Rochemaure, J, 1988) |
| "40 patients with metastatic breast cancer, under treatment with epirubicin (greater than 50 mg/m2) and cyclophosphamide (greater than 500 mg/m2), had an antiemetic therapy with Ondansetron 3 x 8 mg day, for a maximum of 10 cycles." | 5.06 | [Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron]. ( Adler, M; Albrecht, U; Jaenicke, F; Marschner, NW; Nagel, GA, 1990) |
| "19 mg/l with doses which varied considerably owing to marked scattering of pharmacokinetic parameters." | 2.66 | [Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach]. ( Brechot, JM; Delattre, C; Delfour, C; Dupeyron, JP; Guyon, F; Lebeau, B; Rochemaure, J, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inkpen, T | 1 |
| Lissoni, P | 1 |
| Mandalà, M | 1 |
| Rovelli, F | 1 |
| Casu, M | 1 |
| Rocco, F | 1 |
| Tancini, G | 1 |
| Scardino, E | 1 |
| Marschner, NW | 1 |
| Adler, M | 1 |
| Jaenicke, F | 1 |
| Albrecht, U | 1 |
| Nagel, GA | 1 |
| Brechot, JM | 1 |
| Dupeyron, JP | 1 |
| Guyon, F | 1 |
| Delfour, C | 1 |
| Delattre, C | 1 |
| Lebeau, B | 1 |
| Rochemaure, J | 1 |
2 trials available for metoclopramide and Neoplasm Metastasis
| Article | Year |
|---|---|
[Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dou | 1990 |
[Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach].
Topics: Adult; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasm | 1988 |
2 other studies available for metoclopramide and Neoplasm Metastasis
| Article | Year |
|---|---|
Metoclopramide-induced extrapyramidal syndromes.
Topics: Basal Ganglia Diseases; Carcinoma, Renal Cell; Dexamethasone; Female; Humans; Kidney Neoplasms; Meto | 1993 |
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
Topics: Aged; Humans; Hyperprolactinemia; Levodopa; Male; Metoclopramide; Middle Aged; Neoplasm Metastasis; | 2000 |